S. M. Ameen and M. Drancourt, In Vitro Susceptibility of Mycobacterium tuberculosis to Trimethoprim and Sulfonamides in France, Antimicrobial Agents and Chemotherapy, vol.57, issue.12, pp.6370-6371, 2013.
DOI : 10.1128/AAC.01683-13

D. I. Andersson, D. A. Hughes, and L. M. Mundy, Antibiotic resistance and its cost: is it possible to reverse resistance? Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin, Nat. Rev. Microbiol. Int. J. Antimicrob. Agents, vol.8, issue.39, pp.260-271, 2010.

I. Balakrishnan, F. M. Awad-el-kariem, A. Aali, P. Kumari, R. Mulla et al., Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC ??-lactamase-producing Enterobacteriaceae, Journal of Antimicrobial Chemotherapy, vol.66, issue.11, pp.2628-2631, 2011.
DOI : 10.1093/jac/dkr317

V. C. Barry, J. G. Belton, M. L. Conalty, J. M. Denneny, D. W. Edward et al., A New Series of Phenazines (Rimino-Compounds) With High Antituberculosis Activity, Nature, vol.15, issue.4568, pp.1013-1015, 1957.
DOI : 10.1039/jr9560003347

E. Barton, P. Flanagan, and S. Hill, Spinal infection caused by ESBLproducing Klebsiella pneumoniae treated with temocillin, J. Infect, vol.57, 2008.

M. Bassetti, E. Repetto, E. Righi, S. Boni, M. Diverio et al., Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections, Journal of Antimicrobial Chemotherapy, vol.61, issue.2, pp.417-420, 1974.
DOI : 10.1093/jac/dkm509

A. P. Betrosian, F. Frantzeskaki, A. Xanthaki, and E. E. Douzinas, Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia, Journal of Infection, vol.56, issue.6, pp.432-436, 2008.
DOI : 10.1016/j.jinf.2008.04.002

S. Biswas, J. Brunel, J. Dubus, M. Reynaud-gaubert, and J. And-rolain, Colistin: an update on the antibiotic of the 21st century, Expert Review of Anti-infective Therapy, vol.10, issue.8, 2012.
DOI : 10.1586/eri.12.78

A. B. Bosman, J. A. Wagenaar, J. A. Stegeman, J. C. Vernooij, and D. J. Mevius, Antimicrobial resistance in commensal Escherichia coli in veal calves is associated with antimicrobial drug use, Epidemiology and Infection, vol.54, issue.09, pp.1893-1904, 1017.
DOI : 10.1093/jac/47.6.763

P. Brouqui, C. Aubry, M. Million, M. Drancourt, R. et al., Totally resistant tuberculosis: will antileprosy drugs be helpful?, International Journal of Antimicrobial Agents, vol.42, issue.6, pp.584-585, 2013.
DOI : 10.1016/j.ijantimicag.2013.08.004

J. Cadena, S. Nair, A. F. Henao-martinez, J. H. Jorgensen, J. E. Patterson et al., Dose of Trimethoprim-Sulfamethoxazole To Treat Skin and Skin Structure Infections Caused by Methicillin-Resistant Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, vol.55, issue.12, pp.5430-5432, 1128.
DOI : 10.1128/AAC.00706-11

Y. Cai, D. Chai, R. Wang, B. Liang, and N. Bai, Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies, Journal of Antimicrobial Chemotherapy, vol.67, issue.7, pp.1607-1615, 2010.
DOI : 10.1093/jac/dks084

J. A. Caminero, World Health Organization Treatment of multidrug-resistant tuberculosis: evidence and controversies, Int. J. Tuberc. Lung Dis, vol.10, pp.829-837, 2006.

M. L. Campbell, D. Marchaim, J. M. Pogue, B. Sunkara, S. Bheemreddy et al., Treatment of Methicillin-Resistant Staphylococcus aureus Infections with a Minimal Inhibitory Concentration of 2 ??g/mL to Vancomycin: Old (Trimethoprim/Sulfamethoxazole) versus New (Daptomycin or Linezolid) Agents, Annals of Pharmacotherapy, vol.170, issue.7, 2012.
DOI : 10.1345/aph.1R211

J. Casalta, C. Zaratzian, S. Hubert, F. Thuny, F. Gouriet et al., Treatment of Staphylococcus aureus endocarditis with high doses of trimethoprim/sulfamethoxazole and clindamycin???Preliminary report, International Journal of Antimicrobial Agents, vol.42, issue.2, 2013.
DOI : 10.1016/j.ijantimicag.2013.05.002

. Antimicrob, Agents 42, pp.190-191

M. Castanheira, A. A. Watters, R. E. Mendes, D. J. Farrell, and R. N. Jones, Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp, 2008.

M. J. Cenizal, D. Skiest, S. Luber, R. Bedimo, P. Davis et al., Prospective Randomized Trial of Empiric Therapy with Trimethoprim-Sulfamethoxazole or Doxycycline for Outpatient Skin and Soft Tissue Infections in an Area of High Prevalence of Methicillin-Resistant Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, vol.51, issue.7, pp.1353-1358, 1128.
DOI : 10.1128/AAC.00206-07

C. Changchien, Y. Chen, S. Chen, W. Chen, J. Tsay et al., Retrospective study of necrotizing fasciitis and characterization of its associated Methicillin-resistant Staphylococcus aureusin Taiwan, BMC Infectious Diseases, vol.357, issue.1, pp.297-307, 2011.
DOI : 10.1056/NEJMcp070747

A. E. Chen, M. Goldstein, K. Carroll, X. Song, T. M. Perl et al., Evolving Epidemiology of Pediatric Staphylococcus aureus Cutaneous Infections in a Baltimore Hospital, Pediatric Emergency Care, vol.22, issue.10, pp.717-723, 2006.
DOI : 10.1097/01.pec.0000236832.23947.a0

E. Chiang, Y. Su, T. Chen, F. Chiu, C. et al., Comparison of articulating and static spacers regarding infection with resistant organisms in total knee arthroplasty, Acta Orthopaedica, vol.72, issue.2, pp.460-464, 2011.
DOI : 10.1016/S0883-5403(98)90071-7

N. Clumeck, L. Marcelis, M. H. Amiri-lamraski, and B. Gordts, Treatment of severe staphylococcal infections with a rifampicin-minocycline association, Journal of Antimicrobial Chemotherapy, vol.13, issue.suppl C, pp.17-22, 1984.
DOI : 10.1093/jac/13.suppl_C.17

L. A. Collins, G. J. Malanoski, G. M. Eliopoulos, C. B. Wennersten, M. J. Ferraro et al., In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms., Antimicrobial Agents and Chemotherapy, vol.37, issue.3, pp.598-601, 1993.
DOI : 10.1128/AAC.37.3.598

N. Conceição, C. C. De-oliveira, P. R. Da-silva, B. G. Avila, and A. G. De-oliveira, Trends in antimicrobial resistance among clinical isolates of enterococci in a Brazilian tertiary hospital: a 4-year study, Revista da Sociedade Brasileira de Medicina Tropical, vol.44, issue.2, pp.177-181, 1590.
DOI : 10.1590/S0037-86822011005000009

E. C. Cooper, N. Curtis, N. Cranswick, and A. Gwee, Pristinamycin: old drug, new tricks?, Journal of Antimicrobial Chemotherapy, vol.69, issue.9, pp.2319-2325, 2014.
DOI : 10.1093/jac/dku167

B. A. Cunha, Nitrofurantoin, Obstetrical & Gynecological Survey, vol.44, issue.5, pp.399-406, 1989.
DOI : 10.1097/00006254-198905000-00034

B. A. Cunha, Minocycline, often forgotten but preferred to trimethoprim???sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections, International Journal of Antimicrobial Agents, vol.42, issue.6, pp.497-499, 2013.
DOI : 10.1016/j.ijantimicag.2013.08.006

B. A. Cunha, P. E. Schoch, and J. R. Hage, Nitrofurantoin: Preferred Empiric Therapy for Community-Acquired Lower Urinary Tract Infections, Mayo Clinic Proceedings, vol.86, issue.12, 2011.
DOI : 10.4065/mcp.2011.0411

S. J. Dancer, A. Robb, A. Crawford, D. Morrison, V. M. Costa et al., Oral streptogramins in the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections, Journal of Antimicrobial Chemotherapy, vol.51, issue.3, pp.731-735, 1038.
DOI : 10.1093/jac/dkg143

J. L. De-boutin, C. Manuel, J. Charrel, C. Aubert, M. N. Mallet et al., [Value of the aminoglycoside-fosfomycin combination. Apropos of a case of bacterial endocarditis], Pathol. Biol, vol.33, pp.684-686, 1985.

M. De-górgolas, P. Avilés, C. Verdejo, F. Guerrero, and M. L. , Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim- sulfamethoxazole and antibiotics that inhibit cell wall synthesis, Antimicrobial Agents and Chemotherapy, vol.39, issue.4, pp.953-957, 1995.
DOI : 10.1128/AAC.39.4.953

D. Jongh, R. Hens, R. Basma, V. Mouton, J. W. Tulkens et al., Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection, Journal of Antimicrobial Chemotherapy, vol.61, issue.2, pp.382-388, 2008.
DOI : 10.1093/jac/dkm467

P. Demers, D. Fraser, R. B. Goldbloom, J. C. Haworth, J. Larochelle et al., Effects of tetracyclines on skeletal growth and dentition. A report by the Nutrition Committee of the Canadian Paediatric Society, Can. Med. Assoc. J, vol.99, pp.849-854, 1968.

L. M. Deshpande, T. R. Fritsche, G. J. Moet, D. J. Biedenbach, and R. N. Jones, Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program, Diagnostic Microbiology and Infectious Disease, vol.58, issue.2, pp.163-170, 2007.
DOI : 10.1016/j.diagmicrobio.2006.12.022

S. Dewar, L. C. Reed, and R. J. Koerner, Emerging clinical role of pivmecillinam in the treatment of urinary tract infection in the context of multidrug-resistant bacteria, Journal of Antimicrobial Chemotherapy, vol.69, issue.2, pp.303-308, 2014.
DOI : 10.1093/jac/dkt368

D. Carlo, P. D-'alessandro, N. Guadagnino, G. Bonura, C. Mammina et al., High dose of trimethoprim-sulfamethoxazole and daptomycin as a therapeutic option for MRSA endocarditis with large vegetation complicated by embolic stroke: a case report and literature review, Infez. Med, vol.21, pp.45-49, 2013.

S. M. Diene, V. Merhej, M. Henry, A. Filali, V. Roux et al., The Rhizome of the Multidrug-Resistant Enterobacter aerogenes Genome Reveals How New "Killer Bugs" Are Created because of a Sympatric Lifestyle, Molecular Biology and Evolution, vol.30, issue.2, pp.369-383, 2013.
DOI : 10.1093/molbev/mss236

B. A. Diep, H. F. Chambers, C. J. Graber, J. D. Szumowski, L. G. Miller et al., Emergence of Multidrug-Resistant, Community-Associated, Methicillin-Resistant Staphylococcus aureus Clone USA300 in Men Who Have Sex with Men, Annals of Internal Medicine, vol.148, issue.4, pp.249-257, 2008.
DOI : 10.7326/0003-4819-148-4-200802190-00204

A. Dinh, J. Salomon, J. P. Bru, and L. Bernard, Fosfomycin: Efficacy against infections caused by multidrug-resistant bacteria, Scandinavian Journal of Infectious Diseases, vol.27, issue.2, pp.182-189, 2011.
DOI : 10.1016/j.ijantimicag.2009.03.009

M. Drancourt, A. Stein, J. N. Argenson, R. Roiron, P. Groulier et al., Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin, Journal of Antimicrobial Chemotherapy, vol.39, issue.2, pp.235-240, 1997.
DOI : 10.1093/jac/39.2.235

G. Dubourg, J. C. Lagier, F. Armougom, C. Robert, I. Hamad et al., The gut microbiota of a patient with resistant tuberculosis is more comprehensively studied by culturomics than by metagenomics, European Journal of Clinical Microbiology & Infectious Diseases, vol.8, issue.Suppl 4, pp.637-645, 2013.
DOI : 10.1007/s10096-012-1787-3

J. F. Duerinckx, Case Report: Subacute Synovitis of the Knee After a Rose Thorn Injury: Unusual Clinical Picture, Clinical Orthopaedics and Related Research, vol.7, issue.12, pp.3138-3142, 2008.
DOI : 10.1007/s11999-008-0482-2

M. E. Falagas, K. P. Giannopoulou, G. N. Kokolakis, R. , and P. I. , Fosfomycin: Use Beyond Urinary Tract and Gastrointestinal Infections, Clinical Infectious Diseases, vol.46, issue.7, pp.1069-1077, 2008.
DOI : 10.1086/527442

M. E. Falagas and S. K. Kasiakou, Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections, Clinical Infectious Diseases, vol.40, issue.9, pp.1333-1341, 2005.
DOI : 10.1086/429323

M. E. Falagas, S. K. Kasiakou, M. E. Falagas, S. K. Kasiakou, D. P. Kofteridis et al., Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria, European Journal of Clinical Microbiology & Infectious Diseases, vol.50, issue.Suppl 8, pp.596-599, 1007.
DOI : 10.1007/s10096-006-0191-2

M. E. Falagas, A. C. Kastoris, D. E. Karageorgopoulos, R. , and P. I. , Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies, International Journal of Antimicrobial Agents, vol.34, issue.2, pp.111-120, 2009.
DOI : 10.1016/j.ijantimicag.2009.03.009

URL : https://hal.archives-ouvertes.fr/hal-00556337

M. E. Falagas and P. Kopterides, Old antibiotics for infections in critically ill patients, Current Opinion in Critical Care, vol.13, issue.5, pp.592-597, 2007.
DOI : 10.1097/MCC.0b013e32827851d7

M. E. Falagas, P. I. Rafailidis, S. K. Kasiakou, P. Hatzopoulou, and A. Michalopoulos, Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin???meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections, Clinical Microbiology and Infection, vol.12, issue.12, pp.1227-1230, 2006.
DOI : 10.1111/j.1469-0691.2006.01559.x

T. Ferry, I. Uçkay, P. Vaudaux, P. François, J. Schrenzel et al., Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection, European Journal of Clinical Microbiology & Infectious Diseases, vol.39, issue.Suppl 2, pp.171-180, 2009.
DOI : 10.1007/s10096-009-0837-y

G. N. Forrest and K. Tamura, Rifampin Combination Therapy for Nonmycobacterial Infections, Clinical Microbiology Reviews, vol.23, issue.1, pp.14-34, 2010.
DOI : 10.1128/CMR.00034-09

J. G. Frye, J. , and C. R. , Genetic mechanisms of antimicrobial resistance identified in Salmonella enterica, Escherichia coli, and Enteroccocus spp. isolated from U.S. food animals, Frontiers in Microbiology, vol.4, 2013.
DOI : 10.3389/fmicb.2013.00135

T. Fujino, Y. Amari, M. Mohri, M. Noma, and H. Yamamoto, MRSA tricuspid valve infective endocarditis with multiple embolic lung abscesses treated by combination therapy of vancomycin, rifampicin, and sulfamethoxazole/trimethoprim, Journal of Cardiology, vol.53, issue.1, pp.146-149, 2009.
DOI : 10.1016/j.jjcc.2008.06.007

J. Garnacho-montero, C. Ortiz-leyba, F. J. Jiménez-jiménez, A. E. Barrero-almodóvar, J. L. García-garmendia et al., Ventilator???Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem???Susceptible VAP, Clinical Infectious Diseases, vol.36, issue.9, pp.1111-1118, 2003.
DOI : 10.1086/374337

Y. Glupczynski, T. Huang, C. Berhin, G. Claeys, M. Delmée et al., In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care units, European Journal of Clinical Microbiology & Infectious Diseases, vol.56, issue.Suppl. 5, pp.777-783, 2007.
DOI : 10.1007/s10096-007-0370-9

W. Godtfredsen, K. Roholt, and L. Tybring, FUCIDIN, The Lancet, vol.279, issue.7236, pp.928-931, 1962.
DOI : 10.1016/S0140-6736(62)91968-2

E. Goldberg, M. Paul, O. Talker, Z. Samra, M. Raskin et al., Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study, Journal of Antimicrobial Chemotherapy, vol.65, issue.8, pp.1779-1783, 2010.
DOI : 10.1093/jac/dkq179

C. V. Gould, N. O. Fishman, I. Nachamkin, and E. Lautenbach, Conclusions:, Infection Control & Hospital Epidemiology, vol.123, issue.02, pp.138-145, 1086.
DOI : 10.1086/515002

W. Graninger, Pivmecillinam?therapy of choice for lower urinary tract infection, International Journal of Antimicrobial Agents, vol.22, issue.03, pp.73-78, 2003.
DOI : 10.1016/S0924-8579(03)00235-8

K. Gupta, T. M. Hooton, K. G. Naber, B. Wullt, R. Colgan et al., International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases, Clinical Infectious Diseases, vol.52, issue.5, pp.103-120, 2011.
DOI : 10.1093/cid/ciq257

N. D. Gupta, R. E. Smith, and I. Balakrishnan, Clinical efficacy of temocillin, Journal of Antimicrobial Chemotherapy, vol.64, issue.2, pp.431-433, 2009.
DOI : 10.1093/jac/dkp208

A. I. Hidron, C. E. Low, E. G. Honig, and H. M. Blumberg, Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia, The Lancet Infectious Diseases, vol.9, issue.6, pp.384-392, 2009.
DOI : 10.1016/S1473-3099(09)70133-1

B. P. Howden and M. L. Grayson, Dumb and Dumber--The Potential Waste of a Useful Antistaphylococcal Agent: Emerging Fusidic Acid Resistance in Staphylococcus aureus, Clinical Infectious Diseases, vol.42, issue.3, pp.394-400, 2006.
DOI : 10.1086/499365

T. Huang, C. M. Kunin, B. Yan, Y. Chen, S. S. Lee et al., Susceptibility of Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and their combination over a 12 year period in Taiwan, Journal of Antimicrobial Chemotherapy, vol.67, issue.3, pp.633-637, 2012.
DOI : 10.1093/jac/dkr501

F. Jansåker, N. Frimodt-møller, I. Sjögren, D. Knudsen, and J. , Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections, Journal of Antimicrobial Chemotherapy, vol.69, issue.3, pp.769-772, 2014.
DOI : 10.1093/jac/dkt404

M. E. Jiménez-mejías, C. Pichardo-guerrero, F. J. Márquez-rivas, D. Martín-lozano, T. Prados et al., Cerebrospinal Fluid Penetration and Pharmacokinetic/Pharmacodynamic Parameters of Intravenously Administered Colistin in a Case of Multidrug-Resistant Acinetobacter baumannii Meningitis, European Journal of Clinical Microbiology and Infectious Diseases, vol.21, issue.3, pp.212-214, 2002.
DOI : 10.1007/s10096-001-0680-2

H. Kallel, L. Hergafi, M. Bahloul, A. Hakim, H. Dammak et al., Safety and efficacy of colistin compared with imipenem in the treatmentof ventilator-associated pneumonia: a??matched case???control study, Intensive Care Medicine, vol.163, issue.7, pp.1162-1167, 2007.
DOI : 10.1007/s00134-007-0675-2

D. E. Karageorgopoulos, V. Miriagou, L. S. Tzouvelekis, K. Spyridopoulou, D. et al., Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia, 2012.

S. K. Kasiakou, K. Fragoulis, G. Tzagarakis, P. Mistidis, A. Kapaskelis et al., Cure of multidrug-resistant Acinetobacter baumannii fixation device-related orthopedic infections in two patients with intravenous colistin, J. Antimicrob. Chemother. Microb. Drug Resist, vol.67, issue.11, pp.2777-2779, 2005.

S. K. Kasiakou, A. Michalopoulos, E. S. Soteriades, G. Samonis, G. J. Sermaides et al., Combination Therapy with Intravenous Colistin for Management of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in Patients without Cystic Fibrosis, Antimicrobial Agents and Chemotherapy, vol.49, issue.8, pp.3136-31463136, 2005.
DOI : 10.1128/AAC.49.8.3136-3146.2005

G. D. Katopodis, I. N. Grivea, A. J. Tsantsaridou, S. Pournaras, E. Petinaki et al., Fusidic acid and clindamycin resistance in community-associated, methicillin-resistant Staphylococcus aureus infections in children of Central Greece, BMC Infectious Diseases, vol.55, issue.1, pp.351-361, 2010.
DOI : 10.1016/j.annemergmed.2009.03.014

H. Kawada, M. Yamazato, Y. Shinozawa, K. Suzuki, S. Otani et al., [Achievement of sputum culture negative conversion by minocycline in a case with extensively drug-resistant pulmonary tuberculosis], Kekkaku, vol.83, pp.725-728, 2008.

K. Kefala-agoropoulou, E. Protonotariou, D. Vitti, S. Sarafidou, A. Anastasiou et al., Life-threatening infection due to community-acquired methicillin-resistant Staphylococcus aureus: case report and review, European Journal of Pediatrics, vol.5, issue.1, pp.47-53, 2010.
DOI : 10.1007/s00431-009-0977-1

R. M. Klevens, M. A. Morrison, J. Nadle, S. Petit, K. Gershman et al., Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States, JAMA, vol.298, issue.15, pp.1763-1771, 2007.
DOI : 10.1001/jama.298.15.1763

D. P. Kofteridis, C. Alexopoulou, A. Valachis, S. Maraki, D. Dimopoulou et al., Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator???Associated Pneumonia: A Matched Case???Control Study, Clinical Infectious Diseases, vol.51, issue.11, pp.1238-1244, 1086.
DOI : 10.1086/657242

S. Komura and K. Kurahashi, Partial Purification and Properties of L-2, 4-Diaminobutyric Acid Activating Enzyme from a Polymyxin E Producing Organism1, The Journal of Biochemistry, vol.86, issue.4, pp.1013-1021, 1979.
DOI : 10.1093/oxfordjournals.jbchem.a132594

F. Kontopidou, H. Giamarellou, P. Katerelos, A. Maragos, I. Kioumis et al., Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options, Clinical Microbiology and Infection, vol.20, issue.2, pp.117-123, 2014.
DOI : 10.1111/1469-0691.12341

P. Koomanachai, S. Tiengrim, P. Kiratisin, and V. Thamlikitkul, Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand, International Journal of Infectious Diseases, vol.11, issue.5, pp.402-406, 2007.
DOI : 10.1016/j.ijid.2006.09.011

E. Lautenbach, C. V. Gould, L. A. Larosa, A. M. Marr, I. Nachamkin et al., Emergence of resistance to chloramphenicol among vancomycin-resistant enterococcal (VRE) bloodstream isolates, International Journal of Antimicrobial Agents, vol.23, issue.2, pp.200-203, 2004.
DOI : 10.1016/j.ijantimicag.2003.09.011

M. T. Lawlor, M. C. Sullivan, R. E. Levitz, R. Quintiliani, and C. Nightingale, Treatment of Prosthetic Valve Endocarditis Due to Methicillin-Resistant Staphylococcus aureus with Minocycline, Journal of Infectious Diseases, vol.161, issue.4, pp.812-814, 1990.
DOI : 10.1093/infdis/161.4.812

R. Leclercq, C. J. Soussy, P. Weber, N. Moniot-ville, C. Dib et al., Activit?? in vitro de la pristinamycine vis-??-vis des staphylocoques isol??s dans les h??pitaux fran??ais en 1999???2000, vitro activity of the pristinamycin against the isolated staphylococci in the french hospitals, pp.400-404, 1999.
DOI : 10.1016/S0369-8114(03)00054-3

W. Lee, Y. Chen, H. Chen, T. Chen, and C. Cheng, Vertebral osteomyelitis caused by vancomycin-tolerant methicillinresistant Staphylococcus aureus bacteremia: experience with teicoplanin plus fosfomycin combination therapy, J. Microbiol. Immunol. Infect, 2013.

S. Lee, Y. Park, J. K. Yu, S. Jung, Y. Kim et al., Prevalence of acquired fosfomycin resistance among extended-spectrum ??-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3, Journal of Antimicrobial Chemotherapy, vol.67, issue.12, pp.2843-2847, 2012.
DOI : 10.1093/jac/dks319

R. E. Levitz, M. N. Dudley, R. Quintiliani, L. D. Mullany, and C. H. Nightingale, Cerebrospinal fluid penetration of trimethoprim-sulphamethoxazole in two patients with Gram-negative bacillary meningitis, Journal of Antimicrobial Chemotherapy, vol.13, issue.4, pp.400-401, 1984.
DOI : 10.1093/jac/13.4.400

J. Li, R. L. Nation, J. D. Turnidge, R. W. Milne, K. Coulthard et al., Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections, The Lancet Infectious Diseases, vol.6, issue.9, pp.589-601, 2006.
DOI : 10.1016/S1473-3099(06)70580-1

P. K. Linden, S. Kusne, K. Coley, P. Fontes, D. J. Kramer et al., Use of Parenteral Colistin for the Treatment of Serious Infection Due to Antimicrobial-Resistant Pseudomonas aeruginosa, Clinical Infectious Diseases, vol.37, issue.11, pp.154-160, 2003.
DOI : 10.1086/379611

D. M. Livermore, R. Hope, E. J. Fagan, M. Warner, N. Woodford et al., Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England, Journal of Antimicrobial Chemotherapy, vol.57, issue.5, pp.1012-1014, 2006.
DOI : 10.1093/jac/dkl043

D. M. Livermore and P. M. Tulkens, Temocillin revived, Journal of Antimicrobial Chemotherapy, vol.63, issue.2, pp.243-245, 2009.
DOI : 10.1093/jac/dkn511

D. M. Livermore, M. Warner, S. Mushtaq, M. Doumith, J. Zhang et al., What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline, International Journal of Antimicrobial Agents, vol.37, issue.5, pp.415-419, 2011.
DOI : 10.1016/j.ijantimicag.2011.01.012

URL : https://hal.archives-ouvertes.fr/hal-00685788

K. S. Long and B. Vester, Resistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome, Antimicrobial Agents and Chemotherapy, vol.56, issue.2, pp.603-612, 2012.
DOI : 10.1128/AAC.05702-11

Q. Lu, R. Luo, L. Bodin, J. Yang, N. Zahr et al., Efficacy of High-dose Nebulized Colistin in Ventilator-associated Pneumonia Caused by Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, Anesthesiology, vol.117, issue.6, pp.1335-1347, 2012.
DOI : 10.1097/ALN.0b013e31827515de

N. Markou, H. Apostolakos, C. Koumoudiou, M. Athanasiou, A. Koutsoukou et al., Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients Trimethoprimsulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection, Crit Care Ann. Intern. Med, vol.7, issue.7326, pp.78-83, 1992.

G. Martínez-aguilar, W. A. Hammerman, E. O. Mason, S. L. Kaplan, A. Mastoraki et al., Clindamycin treatment of invasive infections caused by communityacquired , methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children Pseudomonas aeruginosa susceptible only to colistin in intensive care unit patients, Pediatr. Infect. Dis. J. Surg. Infect. (Larchmt, vol.22, issue.9, pp.593-598, 2003.

R. F. Mcgehee, C. B. Smith, C. Wilcox, F. , and M. , Comparative Studies of Antibacterial Activity In Vitro and Absorption and Excretion of Lincomycin and Clinimycin, The American Journal of the Medical Sciences, vol.256, issue.5, pp.279-292, 1968.
DOI : 10.1097/00000441-196811000-00002

N. J. Mehta, I. A. Khan, R. N. Mehta, and A. Gulati, Stenotrophomonas maltophilia endocarditis of prosthetic aortic valve: Report of a case and review of literature, Heart & Lung: The Journal of Acute and Critical Care, vol.29, issue.5, pp.351-355, 2000.
DOI : 10.1067/mhl.2000.108362

A. K. Merkier, M. C. Rodríguez, A. Togneri, S. Brengi, C. Osuna et al., Outbreak of a Cluster with Epidemic Behavior Due to Serratia marcescens after Colistin Administration in a Hospital Setting, Journal of Clinical Microbiology, vol.51, issue.7, pp.2295-2302, 1128.
DOI : 10.1128/JCM.03280-12

A. S. Michalopoulos and M. E. Falagas, Inhaled antibiotics in mechanically ventilated patients, Minerva Anestesiol, vol.80, pp.236-244, 2014.

A. Michalopoulos, S. Virtzili, P. Rafailidis, G. Chalevelakis, M. Damala et al., Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation, Clinical Microbiology and Infection, vol.16, issue.2, pp.184-186, 2010.
DOI : 10.1111/j.1469-0691.2009.02921.x

A. Mirakhur, M. J. Gallagher, M. J. Ledson, C. A. Hart, and M. J. Walshaw, Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis, Journal of Cystic Fibrosis, vol.2, issue.1, pp.19-24, 2003.
DOI : 10.1016/S1569-1993(02)00143-1

C. D. Mitnick, S. S. Shin, K. J. Seung, M. L. Rich, S. S. Atwood et al., Comprehensive Treatment of Extensively Drug-Resistant Tuberculosis, New England Journal of Medicine, vol.359, issue.6, pp.563-574, 1056.
DOI : 10.1056/NEJMoa0800106

A. F. Mohamed, I. Karaiskos, D. Plachouras, M. Karvanen, K. Pontikis et al., Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill, Antimicrobial Agents and Chemotherapy, vol.56, issue.8, pp.4241-4249, 1128.
DOI : 10.1128/AAC.06426-11

G. J. Moran, A. Krishnadasan, R. J. Gorwitz, G. E. Fosheim, L. K. Mcdougal et al., Infections among Patients in the Emergency Department, New England Journal of Medicine, vol.355, issue.7, pp.666-674, 1056.
DOI : 10.1056/NEJMoa055356

F. Moreno, J. H. Jorgensen, and M. H. Weiner, An old antibiotic for a new multiple-resistant Enterococcus faecium?, Diagnostic Microbiology and Infectious Disease, vol.20, issue.1, pp.41-43, 1994.
DOI : 10.1016/0732-8893(94)90017-5

S. Motaouakkil, B. Charra, A. Hachimi, H. Nejmi, A. Benslama et al., Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii, Journal of Infection, vol.53, issue.4, pp.274-278, 2006.
DOI : 10.1016/j.jinf.2005.11.019

J. W. Mouton, P. G. Ambrose, R. Canton, G. L. Drusano, S. Harbarth et al., Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective, Drug Resistance Updates, vol.14, issue.2, pp.107-117, 2011.
DOI : 10.1016/j.drup.2011.02.005

S. Muhammed-ameen, J. Rolain, M. Le-poullain, V. Roux, D. Raoult et al., Serum concentration of co-trimoxazole during a high-dosage regimen, Journal of Antimicrobial Chemotherapy, vol.69, issue.3, pp.757-760, 2014.
DOI : 10.1093/jac/dkt400

R. J. Murray, J. C. Pearson, G. W. Coombs, J. P. Flexman, C. L. Golledge et al., Conclusions., Infection Control & Hospital Epidemiology, vol.2, issue.09, pp.859-865, 2008.
DOI : 10.1086/590260

J. P. Nadler, J. Berger, J. A. Nord, R. Cofsky, and M. Saxena, Amoxicillin-Clavulanic Acid for Treating Drug-Resistant Mycobacterium tuberculosis, Chest, vol.99, issue.4, pp.1025-1026, 1991.
DOI : 10.1378/chest.99.4.1025

A. Nather, V. David, H. T. Hee, and J. Thambiah, Pyogenic Vertebral Osteomyelitis: A Review of 14 Cases, Journal of Orthopaedic Surgery, vol.75, issue.3, pp.240-244, 2005.
DOI : 10.1177/230949900501300305

C. Navarro-san-francisco, M. Mora-rillo, M. P. Romero-gómez, F. Moreno-ramos, A. Rico-nieto et al., Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge, Clinical Microbiology and Infection, vol.19, issue.2, pp.72-79, 2013.
DOI : 10.1111/1469-0691.12091

M. L. Nelson, S. B. Levy, J. Sekeres, G. S. Hall, and D. Van-duin, The history of the tetracyclines, Annals of the New York Academy of Sciences, vol.46, issue.1, pp.17-32, 1128.
DOI : 10.1111/j.1749-6632.2011.06354.x

J. Ng and I. B. Gosbell, Successful oral pristinamycin therapy for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA) and other Staphylococcus spp., Journal of Antimicrobial Chemotherapy, vol.55, issue.6, pp.1008-1012, 2005.
DOI : 10.1093/jac/dki108

S. Nguyen, A. Pasquet, L. Legout, E. Beltrand, L. Dubreuil et al., Efficacy and tolerance of rifampicin???linezolid compared with rifampicin???cotrimoxazole combinations in prolonged oral therapy for bone and joint infections, Clinical Microbiology and Infection, vol.15, issue.12, pp.1163-1169, 2009.
DOI : 10.1111/j.1469-0691.2009.02761.x

L. E. Nicolle and M. R. Mulvey, Successful treatment of ctx-m ESBL producing Escherichia coli relapsing pyelonephritis with long term pivmecillinam. Scand, J. Infect. Dis, vol.39, pp.748-749, 2007.

A. H. Norris, J. P. Reilly, P. H. Edelstein, P. J. Brennan, and M. G. Schuster, Chloramphenicol for the Treatment of Vancomycin-Resistant Enterococcal Infections, Clinical Infectious Diseases, vol.20, issue.5, pp.1137-1144, 1995.
DOI : 10.1093/clinids/20.5.1137

O. Neill, B. J. Hirpara, K. M. Kaar, and T. K. , Successful treatment of chronic osteomyelitis of the radius. ISRN Pediatr, pp.154878-154888, 2011.

E. A. Oostdijk, L. Smits, A. M. De-smet, M. A. Leverstein-van-hall, J. Kesecioglu et al., Colistin resistance in gram-negative bacteria during prophylactic topical colistin use in intensive care units, Intensive Care Medicine, vol.33, issue.Suppl 1, pp.653-660, 2013.
DOI : 10.1007/s00134-012-2761-3

Y. K. Park, J. Y. Choi, D. Shin, and K. S. Ko, Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii, International Journal of Antimicrobial Agents, vol.37, issue.6, pp.525-530, 2011.
DOI : 10.1016/j.ijantimicag.2011.02.008

S. N. Patel, N. Memari, D. Shahinas, B. Toye, F. B. Jamieson et al., Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada, Diagnostic Microbiology and Infectious Disease, vol.77, issue.4, pp.350-353, 2013.
DOI : 10.1016/j.diagmicrobio.2013.08.012

F. Pea and P. Viale, Pharmacodynamics of antibiotics to treat multidrugresistant Gram-positive hospital infections, Expert Rev. Anti Infect. Ther, vol.5, 2007.

P. Mato, S. Robinson, S. Bégué, and R. E. , VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM MENINGITIS SUCCESSFULLY TREATED WITH CHLORAMPHENICOL, The Pediatric Infectious Disease Journal, vol.18, issue.5, pp.483-484, 1999.
DOI : 10.1097/00006454-199905000-00023

M. A. Pfaller, M. Castanheira, H. S. Sader, and R. N. Jones, Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada, International Journal of Antimicrobial Agents, vol.35, issue.3, pp.282-287, 2010.
DOI : 10.1016/j.ijantimicag.2009.10.023

J. D. Pitout, L. , and K. B. , Extended-spectrum ??-lactamase-producing Enterobacteriaceae: an emerging public-health concern, The Lancet Infectious Diseases, vol.8, issue.3, pp.159-166, 2008.
DOI : 10.1016/S1473-3099(08)70041-0

J. M. Pogue, D. Marchaim, D. Kaye, K. , and K. S. , Revisiting ???Older??? Antimicrobials in the Era of Multidrug Resistance, Pharmacotherapy, vol.117, issue.9, pp.912-921, 2011.
DOI : 10.1016/j.ijantimicag.2010.09.002

K. Pontikis, I. Karaiskos, S. Bastani, G. Dimopoulos, M. Kalogirou et al., Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria, International Journal of Antimicrobial Agents, vol.43, issue.1, pp.52-59, 2014.
DOI : 10.1016/j.ijantimicag.2013.09.010

H. O. Poulsen, A. Johansson, S. Granholm, G. Kahlmeter, M. M. Sundqvist et al., High genetic diversity of nitrofurantoin-or mecillinam-resistant Escherichia coli indicates low propensity for clonal spread Multidrug-resistant Ewingella americana: a case report and review of the literature, J. Antimicrob. Chemother. Ann. Pharmacother, vol.68, issue.41, pp.2066-2070, 1974.

R. A. Proctor, Role of folate antagonists in the treatment of methicillinresistant Staphylococcus aureus infection, Clin. Infect. Dis, vol.46, pp.584-593, 2008.

C. Pulcini, K. Bush, W. A. Craig, N. Frimodt-møller, M. L. Grayson et al., Forgotten Antibiotics: An Inventory in Europe, the United States, Canada, and Australia, Clinical Infectious Diseases, vol.54, issue.2, pp.268-274, 2007.
DOI : 10.1093/cid/cir838

C. Quentin, F. Grobost, I. Fischer, B. Dutilh, J. P. Brochet et al., R??sistance aux antibiotiques de Staphylococcus aureus en pratique de ville : ??tude sur six mois en Aquitaine, Pathologie Biologie, vol.49, issue.1, pp.33-40, 2001.
DOI : 10.1016/S0369-8114(00)00008-0

R. M. Raz, R. C. Stern, M. A. O-'riordan, and J. L. Blumer, Fosfomycin: an old?new antibiotic The pharmacokinetics of colistin in patients with cystic fibrosis, Clin. Microbiol. Infect. J. Clin. Pharmacol, vol.18, issue.41, pp.645-654, 2001.

A. B. Reid, J. R. Daffy, P. Stanley, and K. L. Buising, Use of Pristinamycin for Infections by Gram-Positive Bacteria: Clinical Experience at an Australian Hospital, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.3949-3952, 2010.
DOI : 10.1128/AAC.00212-10

J. C. Ricaurte, H. W. Boucher, G. S. Turett, R. C. Moellering, V. J. Labombardi et al., Chloramphenicol treatment for vancomycin-resistant Enterococcus faecium bacteremia, Clinical Microbiology and Infection, vol.7, issue.1, pp.17-21, 2001.
DOI : 10.1046/j.1469-0691.2001.00189.x

M. C. Roberts, Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes, FEMS Microbiology Letters, vol.282, issue.2, pp.147-159, 2008.
DOI : 10.1111/j.1574-6968.2008.01145.x

A. Rodríguez, A. Gallego, T. Olay, and J. M. Mata, Bacteriological Evaluation of Fosfomycin in Clinical Studies, Chemotherapy, vol.23, issue.1, pp.247-258, 1977.
DOI : 10.1159/000222055

H. Rodriguez-villalobos, V. Malaviolle, J. Frankard, R. De-mendonça, C. Nonhoff et al., In vitro activity of temocillin against extended spectrum ??-lactamase-producing Escherichia coli, Journal of Antimicrobial Chemotherapy, vol.57, issue.4, pp.771-774, 2006.
DOI : 10.1093/jac/dkl046

J. Rolain, S. M. Diene, M. Kempf, G. Gimenez, C. Robert et al., Real-Time Sequencing To Decipher the Molecular Mechanism of Resistance of a Clinical Pan-Drug-Resistant Acinetobacter baumannii Isolate from Marseille, France, Antimicrobial Agents and Chemotherapy, vol.57, issue.1, pp.592-596, 1128.
DOI : 10.1128/AAC.01314-12

URL : https://hal.archives-ouvertes.fr/hal-01389302

G. Acinetobacter-baumannii-resistant, C. Lartigue, M. D. Boudigue, and F. Maissin, [Infection of the valves of CSF shunts. Results of local and general antibiotic treatment in 6 cases], J. Infect. Dis. Neurochirurgie, vol.204, issue.31, pp.1146-1147, 1985.

J. J. Ruhe and A. Menon, Tetracyclines as an Oral Treatment Option for Patients with Community Onset Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, vol.51, issue.9, pp.3298-3303, 2007.
DOI : 10.1128/AAC.00262-07

J. J. Ruhe, T. Monson, R. W. Bradsher, and A. Menon, Use of Long-Acting Tetracyclines for Methicillin-Resistant Staphylococcus aureus Infections: Case Series and Review of the Literature, Clinical Infectious Diseases, vol.40, issue.10, pp.1429-1434, 2005.
DOI : 10.1086/429628

J. J. Ruhe, N. Smith, R. W. Bradsher, and A. Menon, Community-Onset Methicillin-Resistant Staphylococcus aureus Skin and Soft-Tissue Infections: Impact of Antimicrobial Therapy on Outcome, Clinical Infectious Diseases, vol.44, issue.6, pp.777-784, 2007.
DOI : 10.1086/511872

N. Ruparelia, B. L. Atkins, J. Hemingway, A. R. Berendt, and I. Byren, Pristinamycin as adjunctive therapy in the management of Gram-positive multi-drug resistant organism (MDRO) osteoarticular infection, Journal of Infection, vol.57, issue.3, pp.191-197, 2008.
DOI : 10.1016/j.jinf.2008.07.002

L. Sandegren, A. Lindqvist, G. Kahlmeter, and D. I. Andersson, Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli, Journal of Antimicrobial Chemotherapy, vol.62, issue.3, 2008.
DOI : 10.1093/jac/dkn222

P. G. Scapellato, C. Ormazabal, J. L. Scapellato, and E. G. Bottaro, Meningitis Due to Vancomycin-Resistant Enterococcus faecium Successfully Treated with Combined Intravenous and Intraventricular Chloramphenicol, Journal of Clinical Microbiology, vol.43, issue.7, pp.495-503, 2005.
DOI : 10.1128/JCM.43.7.3578-3579.2005

B. S. Schwartz, C. J. Graber, B. A. Diep, L. Basuino, F. Perdreau-remington et al., Clone USA300, Clinical Infectious Diseases, vol.48, issue.10, pp.1483-1484, 2009.
DOI : 10.1086/598510

S. J. Seligman, T. Madhavan, A. , and D. , Trimethoprim-Sulfamethoxazole in The Treatment of Bacterial Endocarditis, Journal of Infectious Diseases, vol.128, issue.Supplement 3, pp.754-761, 1973.
DOI : 10.1093/infdis/128.Supplement_3.S754

S. Senol, M. Tasbakan, H. Pullukcu, O. R. Sipahi, H. Sipahi et al., -Related Complicated Lower Urinary Tract Infection, Journal of Chemotherapy, vol.1994, issue.1, pp.355-357, 2010.
DOI : 10.1007/s10096-004-1264-8

URL : https://hal.archives-ouvertes.fr/hal-00527566

H. Seppälä, T. Klaukka, J. Vuopio-varkila, A. Muotiala, H. Helenius et al., The Effect of Changes in the Consumption of Macrolide Antibiotics on Erythromycin Resistance in Group A Streptococci in Finland, New England Journal of Medicine, vol.337, issue.7, pp.441-446, 1971.
DOI : 10.1056/NEJM199708143370701

K. Shean, E. Streicher, E. Pieterson, G. Symons, R. Van-zyl-smit et al., Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa, PLoS One, vol.8, 2013.

G. K. Siberry, T. Tekle, K. Carroll, D. , and J. , Failure of Clindamycin Treatment of Methicillin-Resistant Staphylococcus aureus Expressing Inducible Clindamycin Resistance In Vitro, Clinical Infectious Diseases, vol.37, issue.9, pp.1257-1260, 2003.
DOI : 10.1086/377501

M. H. Silbermann, I. C. Gyssens, J. J. Wielenga, H. P. Endtz, and B. Löwenberg, [A patient with acute leukemia and meningitis caused by Staphylococcus epidermidis treated with fosfomycin], Ned. Tijdschr. Geneeskd, vol.139, pp.2498-2501, 1995.

B. Slocombe, M. J. Basker, P. H. Bentley, J. P. Clayton, M. Cole et al., BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans., Antimicrobial Agents and Chemotherapy, vol.20, issue.1, pp.38-46, 1981.
DOI : 10.1128/AAC.20.1.38

J. Y. Song, J. Lee, J. Y. Heo, J. Y. Noh, W. J. Kim et al., Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii, International Journal of Antimicrobial Agents, vol.32, issue.3, 2008.
DOI : 10.1016/j.ijantimicag.2008.04.013

A. Søraas, A. Sundsfjord, S. B. Jørgensen, K. Liestøl, and P. A. Jenum, High Rate of Per Oral Mecillinam Treatment Failure in Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Escherichia coli, PLoS ONE, vol.30, issue.1, 2014.
DOI : 10.1371/journal.pone.0085889.t004

B. Spellberg, J. H. Powers, E. P. Brass, L. G. Miller, and J. E. Edwards, Trends in Antimicrobial Drug Development: Implications for the Future, Clinical Infectious Diseases, vol.38, issue.9, pp.1279-1286, 2004.
DOI : 10.1086/420937

A. Stein, J. F. Bataille, M. Drancourt, G. Curvale, J. N. Argenson et al., Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral cotrimoxazole (trimethoprim-sulfamethoxazole), Antimicrob. Agents Chemother, vol.42, pp.3086-3091, 1998.

D. L. Stevens, A. L. Bisno, H. F. Chambers, E. P. Dellinger, E. J. Goldstein et al., Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections, Clinical Infectious Diseases, vol.41, issue.10, pp.147-159, 1991.
DOI : 10.1086/497143

A. Sullivan, C. Edlund, and C. E. Nord, Effect of antimicrobial agents on the ecological balance of human microflora, The Lancet Infectious Diseases, vol.1, issue.2, pp.101-114, 2001.
DOI : 10.1016/S1473-3099(01)00066-4

M. A. Tamer and J. D. Bray, Trimethoprim-Sulfamethoxazole Treatment of Multiantibiotic-Resistant Staphylococcal Endocarditis and Meningitis, Clinical Pediatrics, vol.64, issue.14, pp.125-126, 1982.
DOI : 10.1177/000992288202100211

M. I. Tasbakan, H. Pullukcu, O. R. Sipahi, T. Yamazhan, and S. Ulusoy, Nitrofurantoin in the treatment of extended-spectrum ??-lactamase-producing Escherichia coli-related lower urinary tract infection, International Journal of Antimicrobial Agents, vol.40, issue.6, pp.554-556, 2012.
DOI : 10.1016/j.ijantimicag.2012.08.003

M. S. Ta¸sbakanta¸sbakan, H. Pullukçu, P. K. Ekren, A. T. Oz, M. Midilli et al., [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii], Mikrobiyol. Bul, vol.43, pp.61-70, 2009.

C. Tascini, G. Gemignani, F. Palumbo, A. Leonildi, A. Tedeschi et al., Diabetic Foot Infections with or Without Osteomyelitis, Journal of Chemotherapy, vol.41, issue.6, pp.648-651, 2006.
DOI : 10.1046/j.1469-0691.2000.00169.x

S. E. Taylor, D. L. Paterson, Y. , V. L. Titelman, E. Iversen et al., Treatment options for chronic prostatitis due to vancomycin-resistant Enterococcus faecium. Eur Efficacy of pivmecillinam for treatment of lower urinary tract infection caused by extendedspectrum ?-lactamase-producing Escherichia coli and Klebsiella pneumoniae, J. Clin. Microbiol. Infect. Dis. Microb. Drug Resist, vol.17, issue.18, pp.798-800, 1998.

T. Rué, M. Usandizaga, F. García-fontecha, C. Bartolomé-comas, R. et al., [Necrotizing fasciitis due to communityacquired panton-valentine leukocidin methicillin resistant Staphylococcus aureus], An. Pediatr, vol.70, pp.374-378, 2009.

K. Trzcinski, B. S. Cooper, W. Hryniewicz, and C. G. Dowson, Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus, Journal of Antimicrobial Chemotherapy, vol.45, issue.6, pp.763-770, 2000.
DOI : 10.1093/jac/45.6.763

M. Tsukamura, S. Mizuno, and H. Toyama, [Combined effect of minocycline with antitubercular agents on Mycobacterium tuberculosis: in vitro study], Kekkaku, vol.58, pp.665-667, 1983.

M. Tumbarello, G. De-pascale, E. M. Trecarichi, D. Martino, S. Bello et al., Effect of Aerosolized Colistin as Adjunctive Treatment on the Outcomes of Microbiologically Documented Ventilator-Associated Pneumonia Caused by Colistin-Only Susceptible Gram-Negative Bacteria, Chest, vol.144, issue.6, pp.1768-1775, 1378.
DOI : 10.1378/chest.13-1018

J. Turnidge, Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics, International Journal of Antimicrobial Agents, vol.12, issue.98, pp.23-34, 1999.
DOI : 10.1016/S0924-8579(98)00071-5

E. E. Udo, N. Al-sweih, E. Mokaddas, M. Johny, R. Dhar et al., Antibacterial resistance and their genetic location in MRSA isolated in Kuwait hospitals, 1994-2004, BMC Infectious Diseases, vol.42, issue.Suppl 2, pp.168-178, 1994.
DOI : 10.1128/JCM.42.6.2792-2795.2004

E. L. Van-der-veen, A. G. Schilder, T. K. Timmers, M. M. Rovers, A. C. Fluit et al., Effect of long-term trimethoprim/sulfamethoxazole treatment on resistance and integron prevalence in the intestinal flora: a randomized , double-blind, placebo-controlled trial in children Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis, J. Antimicrob. Chemother. Am. J. Respir. Crit. Care Med, vol.63, issue.182, pp.1011-1016, 2009.

M. Wachi, M. Doi, S. Tamaki, W. Park, S. Nakajima-iijima et al., Mutant isolation and molecular cloning of mre genes, which determine cell shape, sensitivity to mecillinam, and amount of penicillin-binding proteins in Escherichia coli., Journal of Bacteriology, vol.169, issue.11, pp.4935-4940, 1987.
DOI : 10.1128/jb.169.11.4935-4940.1987

B. Walker, S. Barrett, S. Polasky, V. Galaz, C. Folke et al., Looming Global-Scale Failures and Missing Institutions, Science, vol.325, issue.5946, pp.1345-1346, 2009.
DOI : 10.1126/science.1175325

J. Wang, H. Tang, P. Hsieh, F. Chiu, Y. Chen et al., Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus, International Journal of Antimicrobial Agents, vol.40, issue.2, pp.103-107, 2012.
DOI : 10.1016/j.ijantimicag.2012.03.010

D. Wasyl, A. Hoszowski, M. Zajac, and K. Szulowski, Antimicrobial resistance in commensal Escherichia coli isolated from animals at slaughter, Frontiers in Microbiology, vol.4, 2013.
DOI : 10.3389/fmicb.2013.00221

D. A. Williamson, S. Monecke, H. Heffernan, S. R. Ritchie, S. A. Roberts et al., High Usage of Topical Fusidic Acid and Rapid Clonal Expansion of Fusidic Acid-Resistant Staphylococcus aureus: A Cautionary Tale, Clinical Infectious Diseases, vol.59, issue.10, 2014.
DOI : 10.1093/cid/ciu658

C. R. Wolfe, J. B. Wood, D. B. Smith, E. H. Baker, S. M. Brecher et al., Case Report, Postgraduate Medical Journal, vol.26, issue.292, pp.538-541, 1128.
DOI : 10.1136/pgmj.26.292.92

H. Xu, R. Jiang, X. , and H. , Clofazimine in the treatment of multidrug-resistant tuberculosis, Clinical Microbiology and Infection, vol.18, issue.11, 2012.
DOI : 10.1111/j.1469-0691.2011.03716.x

H. Xu, V. Miao, W. Kwong, R. Xia, and J. Davies, Identification of a novel fosfomycin resistance gene (fosA2) in Enterobacter cloacae from the Salmon River, Canada, Letters in Applied Microbiology, vol.49, issue.4, pp.427-429, 2011.
DOI : 10.1111/j.1472-765X.2011.03016.x

X. Xu, C. Chen, D. Lin, Q. Guo, F. Hu et al., The Fosfomycin Resistance Gene fosB3 Is Located on a Transferable, Extrachromosomal Circular Intermediate in Clinical Enterococcus faecium Isolates, PLoS ONE, vol.18, issue.10, 2013.
DOI : 10.1371/journal.pone.0078106.t001

J. Yoo, J. Lyu, S. D. Lee, W. S. Kim, D. S. Kim et al., Clinical experience of using clofazimine to treat multidrug-resistant tuberculosis [Correspondence], The International Journal of Tuberculosis and Lung Disease, vol.17, issue.9, pp.1243-1244, 2013.
DOI : 10.5588/ijtld.13.0312

J. Zahar, O. Lortholary, C. Martin, G. Potel, P. Plesiat et al., Addressing the challenge of extended-spectrum beta-lactamases, Curr. Opin. Investig. Drugs, vol.10, pp.172-180, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00464775

G. G. Zhanel, N. M. Laing, K. A. Nichol, L. P. Palatnick, A. Noreddin et al., Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS), Journal of Antimicrobial Chemotherapy, vol.52, issue.3, pp.382-388, 2003.
DOI : 10.1093/jac/dkg352